KBI Biopharma, Inc. (KBI) and Selexis SA, both JSR Life Sciences companies, appointed  J.D. Mowery as CEO. Mowery has nearly a 25-year track record of inspiring colleagues and building organizations. He will lead KBI and Selexis into the next chapter of becoming a leader in the next generation of CDMOs that are emerging. “Through decades of service, J.D. has devoted his career to meaningful work with a clear focus on patient impact through the launch of novel therapies and by providi...